Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease
- PMID: 3089660
Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease
Abstract
Meningococcal meningitis is a serious disease with a high incidence in children. Since meningococcal surface structures play a role in invasion of the host and initiation of disease, host defense mechanisms are directed against these meningococcal structures. All virulent meningococci are encapsulated, but other factors are also involved. Only certain serotypes of group B and group C meningococci are strongly associated with disease. Our studies have been directed toward a better understanding of the structure of the meningococcal cell surface. There are five classes of major outer membrane proteins exposed on the cell surface, designated class 1 through 5, based in part upon the protein's molecular weight. Using monoclonal antibodies we have shown that antibodies to the class 1, 2 and 5 proteins of serotype 2 are bactericidal and therefore probably protective. Convalescent sera of meningococcal disease patients have elevated antibody levels to each of these classes of proteins. Outer membrane protein vaccines have been prepared, and clinically evaluated in adults and children as young as 6 mo of age. The vaccines induce serotype specific bactericidal antibodies in all age groups, but they induced lower levels in young children. We are now working to improve the immune response of children through the use of aluminium adjuvants.
Similar articles
-
Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.Cent Eur J Public Health. 1995 Nov;3(4):189-94. Cent Eur J Public Health. 1995. PMID: 8903519
-
Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci.Dev Biol Stand. 1986;63:147-52. Dev Biol Stand. 1986. PMID: 3091433
-
Control of meningococcal meningitis with meningococcal vaccines.Yale J Biol Med. 1975 Jul;48(3):197-200. Yale J Biol Med. 1975. PMID: 808913 Free PMC article. Review.
-
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.Vaccine. 2005 May 31;23(29):3762-74. doi: 10.1016/j.vaccine.2005.02.021. Epub 2005 Mar 14. Vaccine. 2005. PMID: 15893613
-
Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.Clin Infect Dis. 2009 Aug 15;49(4):597-605. doi: 10.1086/603552. Clin Infect Dis. 2009. PMID: 19622040 Review.
Cited by
-
Adolescent Vaccination Strategies: Interventions to Increase Coverage.Paediatr Drugs. 2016 Aug;18(4):273-85. doi: 10.1007/s40272-016-0177-1. Paediatr Drugs. 2016. PMID: 27146296 Review.
-
Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.J Exp Med. 1990 Jun 1;171(6):1871-82. doi: 10.1084/jem.171.6.1871. J Exp Med. 1990. PMID: 1693651 Free PMC article.
-
Thermal stress induced aggregation of aquaporin 0 (AQP0) and protection by α-crystallin via its chaperone function.PLoS One. 2013 Nov 27;8(11):e80404. doi: 10.1371/journal.pone.0080404. eCollection 2013. PLoS One. 2013. PMID: 24312215 Free PMC article.
-
Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins.Infect Immun. 1990 May;58(5):1355-9. doi: 10.1128/iai.58.5.1355-1359.1990. Infect Immun. 1990. PMID: 2157669 Free PMC article.
-
Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.Clin Diagn Lab Immunol. 2000 May;7(3):390-5. doi: 10.1128/CDLI.7.3.390-395.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799451 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources